• Primary Biliary Cholangitis (PBC): Highlights from EASL 2023 - Part 2

  • Dec 6 2023
  • Length: 23 mins
  • Podcast

Primary Biliary Cholangitis (PBC): Highlights from EASL 2023 - Part 2  By  cover art

Primary Biliary Cholangitis (PBC): Highlights from EASL 2023 - Part 2

  • Summary

  • Robert Mitchell-Thain, CEO of the PBC Foundation, Edinburgh, UK and Kath Houghton, Autoimmune Specialist Nurse, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK, discuss their ‘Primary Biliary Cholangitis (PBC) highlights from EASL 2023’ in this podcast.

    Their discussion covers the relationship between initial symptoms and disease trajectory, the association of biochemical control and outcomes in PBC, and the impact and assessment of patient reported outcomes.

    Show more Show less
activate_primeday_promo_in_buybox_DT

What listeners say about Primary Biliary Cholangitis (PBC): Highlights from EASL 2023 - Part 2

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.